UK’s Real-World Data Shows Value Of Initial COVID Vaccines Doses – But Can It Shift Policy Elsewhere?
Executive Summary
Another real-world study from the UK’s rapid vaccine rollout provides evidence that Pfizer’s vaccine saves lives, with the AstraZeneca shot matching it on cutting hospitalizations.
You may also be interested in...
Novavax Sets Out Vaccine Strategy For New COVID-19 Variants
The US company is poised to file with regulators in Q2, but is also looking for longer-term competitive advantage in its variant strategy.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
Precision Keeps Faith In Duchenne Gene-Editing After Lilly’s Exit
The company has pledged to continue developing its Duchenne in vivo gene editing therapy without Lilly, but will remain focused on its lead program in hepatitis B.